Advances in Radioisotope Production Supporting Therapy Growth Reliable isotope supply plays an essential role in the Radioligand Therapy (RLT) Market. Radioactive isotopes used in treatment have limited shelf lives, requiring efficient production and distribution systems. Medical reactors and cyclotrons produce therapeutic isotopes under carefully controlled conditions. Advances in production technology are improving yield consistency and reducing delays. Local manufacturing initiatives are emerging in several regions to reduce dependence on international shipments. Shorter transport times ensure therapies remain effective when delivered to hospitals. Quality assurance procedures remain strict throughout production. Each isotope batch undergoes testing to confirm purity and safety before clinical use. Ref - https://www.marketresearchfuture.com/reports/radioligand-therapy-rlt-market-11824